Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.10
Delayed Data
As of Apr 25
 +0.12 / +4.03%
Today’s Change
1.65
Today|||52-Week Range
6.49
+78.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash183.0M243.4M239.5M182.5M
 
 
 
 
 
Short Term Investment Cash-87.5M10.2M-3.7M18.1M
 
 
 
 
 
Cash & Short Term Investments242.1M264.4M241.0M194.0M
 
 
 
 
 
 
ReceivablesReceivables2.8M2.9M2.1M1.1M
 
 
 
 
 
 
InventoriesInventories15.0M11.5M24.0M23.2M
 
 
 
 
 
 
Current AssetsOther Current Assets2.6M4.0M6.1M6.2M
 
 
 
 
 
Current Assets262.4M282.7M273.2M224.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.7M3.8M3.8M3.7M
 
 
 
 
 
Depreciation-2.3M-2.4M-2.5M-2.6M
 
 
 
 
 
Intangible Assets0.00--78.0M76.1M
 
 
 
Other Assets60.9M61.2M81.2M78.9M
 
 
 
 
 
Total Assets375.0M345.4M355.8M304.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.6M4.1M12.0M15.2M
 
 
 
 
 
Accrued Expenses14.1M17.4M18.8M12.9M
 
 
 
 
 
Other Current Liabilities23.7M27.3M48.0M42.8M
 
 
 
 
 
Other Liabilities30.4M34.8M65.5M65.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt209.0M206.4M200.9M166.2M
 
 
 
 
 
Other Liabilities41.1M33.1M0.000.00
 
 
 
Total Liabilities360.7M352.1M279.1M244.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock3.3M3.3M3.3M3.3M
 
 
 
 
 
Common Equity10.9M-10.0M73.4M57.0M
 
 
 
 
 
Total Shareholder Equity14.2M-6.7M76.8M60.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.6M14.6M14.6M14.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.